Mads Agerbæk

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

Clinical epidemiology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Aarhus Universitetshospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aarhus Universitetshospital

Denmark

Consultant, MD :: Onkologisk Afdeling

Publications

Thomas Wagner, Jakob Lauritsen, Mikkel Bandak, Linda Aagaard Rasmussen, Johannes Bakker, Hanna Birkbak Hovaldt, Heidi Larsson, Ib Jarle Christensen, Birgitte Grønkær Toft, Mads Agerbæk, Lars Dysager, Michael Kreiberg, Josephine Julie Rosenvilde, Birte Engvad, Daniel M Berney, Gedske Daugaard
A Validated Algorithm for Register-Based Identification of Patients with Relapse of Clinical Stage I Testicular Cancer. Clinical epidemiology 15 (2023)
Sia Viborg Lindskrog, Karin Birkenkamp-Demtröder, Iver Nordentoft, Georgios I Laliotis, Philippe Lamy, Emil Christensen, Derrick Renner, Tine G Andreasen, Naja Lange, Shruti Sharma, Adam C ElNaggar, Minetta C Liu, Himanshu Sethi, Alexey Aleshin, Mads Agerbæk, Jørgen Bjerggaard Jensen, Lars Dyrskjøt
Circulating tumor DNA analysis in advanced urothelial carcinoma: insights from biological analysis and extended clinical follow-up. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Thomas Wagner, Birgitte Grønkær Toft, Jakob Lauritsen, Mikkel Bandak, Ib Jarle Christensen, Birte Engvad, Michael Kreiberg, Mads Agerbæk, Lars Dysager, Josephine Julie Rosenvilde, Daniel M Berney, Gedske Daugaard
Prognostic Factors for Relapse in Patients With Clinical Stage I Testicular Seminoma: A Nationwide, Population-Based Cohort Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Emil Christensen, Iver Nordentoft, Karin Birkenkamp-Demtröder, Sara K Elbæk, Sia Viborg Lindskrog, Ann Taber, Tine G Andreasen, Trine Strandgaard, Michael Knudsen, Philippe Lamy, Mads Agerbæk, Jørgen Bjerggaard Jensen, Lars Dyrskjøt
Cell-free urine- and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle invasive bladder cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ann Taber, Emil Christensen, Philippe Lamy, Iver Nordentoft, Frederik Prip, Sia Viborg Lindskrog, Karin Birkenkamp-Demtröder, Trine Line Hauge Okholm, Michael Knudsen, Jakob Skou Pedersen, Torben Steiniche, Mads Agerbæk, Jørgen Bjerggaard Jensen, Lars Dyrskjøt
Author Correction: Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis. Nature communications 13 (1) (2022)
Signe Sørup, Bianka Darvalics, Azza Ahmed Khalil, Marianne Nordsmark, Mette Hæe, Frede Donskov, Mads Agerbæk, Leo Russo, Dina Oksen, Emmanuelle Boutmy, Patrice Verpillat, Deirdre P Cronin-Fenton
Treatment and Survival in Advanced Non-Small Cell Lung Cancer, Urothelial, Ovarian, Gastric and Kidney Cancer: A Nationwide Comprehensive Evaluation. Clinical epidemiology 13 (2021)
Ann Taber, Emil Christensen, Philippe Lamy, Iver Nordentoft, Frederik Prip, Sia Viborg Lindskrog, Karin Birkenkamp-Demtröder, Trine Line Hauge Okholm, Michael Knudsen, Jakob Skou Pedersen, Torben Steiniche, Mads Agerbæk, Jørgen Bjerggaard Jensen, Lars Dyrskjøt
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis. Nature communications 11 (1) (2020)

Mads Agerbæk.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mads Agerbæk